Alessandro Bucalossi

646 total citations
26 papers, 379 citations indexed

About

Alessandro Bucalossi is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Alessandro Bucalossi has authored 26 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Genetics and 5 papers in Oncology. Recurrent topics in Alessandro Bucalossi's work include Multiple Myeloma Research and Treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Alessandro Bucalossi is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Alessandro Bucalossi collaborates with scholars based in Italy. Alessandro Bucalossi's co-authors include Piero Galieni, Giuseppe Marotta, Catia Bigazzi, Francesco Lauria, Domenico Russo, Monica Bocchia, Alessandro Pulsoni, Rosanna Falbo, Michèle Cavo and Maria Teresa Petrucci and has published in prestigious journals such as Journal of Clinical Microbiology, Annals of Oncology and Acta Neuropathologica.

In The Last Decade

Alessandro Bucalossi

24 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandro Bucalossi Italy 11 218 160 97 89 88 26 379
Chad P. Soupir United States 8 182 0.8× 92 0.6× 42 0.4× 52 0.6× 64 0.7× 9 304
F. M. Fink Austria 11 190 0.9× 60 0.4× 68 0.7× 70 0.8× 125 1.4× 21 439
Bérengère Gruson France 10 166 0.8× 101 0.6× 51 0.5× 76 0.9× 56 0.6× 21 328
Tamara Berno Italy 11 168 0.8× 108 0.7× 148 1.5× 59 0.7× 117 1.3× 46 356
Hien K. Duong United States 8 261 1.2× 107 0.7× 100 1.0× 29 0.3× 104 1.2× 30 425
Dorthe Rønnov‐Jessen Denmark 9 293 1.3× 159 1.0× 59 0.6× 100 1.1× 75 0.9× 14 465
Cecilia Isaksson Sweden 7 238 1.1× 56 0.3× 94 1.0× 119 1.3× 33 0.4× 9 367
Rocco Pastano Italy 10 177 0.8× 74 0.5× 66 0.7× 64 0.7× 80 0.9× 19 285
Claire Petry Switzerland 10 187 0.9× 89 0.6× 61 0.6× 84 0.9× 44 0.5× 14 342
Marcio Andrade‐Campos Spain 11 148 0.7× 109 0.7× 46 0.5× 77 0.9× 75 0.9× 34 328

Countries citing papers authored by Alessandro Bucalossi

Since Specialization
Citations

This map shows the geographic impact of Alessandro Bucalossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Bucalossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Bucalossi more than expected).

Fields of papers citing papers by Alessandro Bucalossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Bucalossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Bucalossi. The network helps show where Alessandro Bucalossi may publish in the future.

Co-authorship network of co-authors of Alessandro Bucalossi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Bucalossi. A scholar is included among the top collaborators of Alessandro Bucalossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Bucalossi. Alessandro Bucalossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pettini, Elena, Annalisa Ciabattini, Fabio Fiorino, et al.. (2024). Spike-Specific Memory B Cell Response in Hematopoietic Cell Transplantation Recipients following Multiple mRNA-1273 Vaccinations: A Longitudinal Observational Study. Vaccines. 12(4). 368–368. 3 indexed citations
3.
Guarnieri, Andrea, et al.. (2022). [The genetic basis of post-bone marrow transplant thrombotic microangiopathy: is this the last piece of the puzzle?]. PubMed. 39(1).
4.
Guerrini, Susanna, Alessandro Bucalossi, Nevada Cioffi Squitieri, et al.. (2015). Ischemic Colitis Diagnosed by Magnetic Resonance Imaging during Lenalidomide Treatment in a Patient with Relapsed Multiple Myeloma. Tumori Journal. 102(2_suppl). S110–S112. 8 indexed citations
5.
Bucalossi, Alessandro, et al.. (2010). Thrombotic Microangiopathy and Occult Neoplasia. Cardiovascular & Haematological Disorders - Drug Targets. 10(2). 87–93. 1 indexed citations
6.
Gozzetti, Alessandro, Alfonso Cerase, Alessandro Bucalossi, et al.. (2008). Unusual Discordant Responses in Two Multiple Myeloma Patients during Bortezomib Treatment. Onkologie. 31(1-2). 45–47. 9 indexed citations
7.
8.
Mazzotta, Serena, Alessandro Gozzetti, Monica Bocchia, et al.. (2005). Low-dose thalidomide-induced agranulocytosis in a multiple myeloma patient treated at diagnosis. Leukemia & lymphoma. 46(12). 1837–1838. 1 indexed citations
9.
Mazzotta, Serena, Silvia Gentili, M. Lenoci, et al.. (2004). Disseminated Mucormycosis in a Patient with Acute Myeloblastic Leukemia Misdiagnosed as Infection by Enterococcus faecium. Journal of Clinical Microbiology. 42(1). 487–489. 4 indexed citations
10.
Russo, Domenico, Mariagrazia Michieli, Angela Michelutti, et al.. (2001). Fludarabine, Arabinosyl Cytosine and Idarubicin (FLAI) for Remission Induction in Poor-Risk Acute Myeloid Leukemia. Leukemia & lymphoma. 40(3-4). 335–343. 15 indexed citations
11.
Laszlò, Daniele, Piero Galieni, Donatella Raspadori, et al.. (2000). “Fludarabine Containing-Regimens May Adversely Affect Peripheral Blood Stem Cell Collection in Low-Grade Non Hodgkin Lymphoma Patients”. Leukemia & lymphoma. 37(1-2). 157–161. 40 indexed citations
12.
Marotta, Giuseppe, Alessandro Bucalossi, Piero Galieni, et al.. (1998). CD4+/CD45RA+ ‘Naive' T Cells and Immunological Response to Influenza Virus Vaccine in B-Cell Chronic Lymphocytic Leukaemia Patients. Acta Haematologica. 99(1). 18–21. 6 indexed citations
13.
Sacchi, Stefano, L Gugliotta, Federico Papineschi, et al.. (1998). Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone. Leukemia. 12(3). 289–294. 16 indexed citations
14.
15.
Galieni, Piero, Giuseppe Marotta, Daniela Diverio, et al.. (1996). Variant t(1;15;17)(q23;q22;q23) in a case of acute promyelocytic leukemia.. PubMed. 10(10). 1658–61. 11 indexed citations
16.
Sacchi, Stefano, L Gugliotta, Federico Papineschi, et al.. (1996). ALPHA-INTERFERON IN THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA: CLINICAL RESULTS AND EVALUATION OF ITS BIOLOGICAL EFFECTS ON THE HEMATOPOIETIC NEOPLASTIC CLONE.. IRIS UNIMORE (University of Modena and Reggio Emilia). 581–581. 1 indexed citations
17.
Galieni, Piero, Michèle Cavo, Giuseppe Avvisati, et al.. (1995). Solitary plasmacytoma of bone and extramedullary plasmacytoma: Two different entities?. Annals of Oncology. 6(7). 687–691. 67 indexed citations
18.
Malandrini, Alessandro, et al.. (1994). Atypical McLeod syndrome manifested as X-linked chorea-acanthocytosis, neuromyopathy and dilated cardiomyopathy: report of a family. Journal of the Neurological Sciences. 124(1). 89–94. 33 indexed citations
19.
Papineschi, Federico, Alessandro Bucalossi, Enrico Capochiani, et al.. (1994). Recombinant α2a interferon and polycythemia vera: Clinical results and biological evaluation by means of Fourier‐transform infrared microspectroscopy. European Journal Of Haematology. 53(4). 213–217. 14 indexed citations
20.
Malandrini, Alessandro, Giancarlo Fabrizi, Silvia Palmeri, et al.. (1993). Choreo-acanthocytosis like phenotype without acanthocytes: clinicopathological case report. Acta Neuropathologica. 86(6). 651–658. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chad P. Soupir Breakdown of academic impact, for papers by F. M. Fink Breakdown of academic impact, for papers by Bérengère Gruson Breakdown of academic impact, for papers by Tamara Berno Breakdown of academic impact, for papers by Hien K. Duong Breakdown of academic impact, for papers by Dorthe Rønnov‐Jessen Breakdown of academic impact, for papers by Cecilia Isaksson Breakdown of academic impact, for papers by Rocco Pastano Breakdown of academic impact, for papers by Claire Petry Breakdown of academic impact, for papers by Marcio Andrade‐Campos
Rankless by CCL
2026